Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Yeh

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
JAAD Case Reports|March 25, 2017
Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumabJennifer E Yeh, William G Tsiaras
Chemmedchem|December 15, 2015
STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer TherapyJennifer E Yeh, David A Frank
Dermatology Online Journal|August 1, 2024
Chronic ulcer in a patient with essential thrombocythemia taking hydroxyureaNolan Maloney, Roberto Novoa, Jennifer E Yeh
Dermatology Online Journal|February 23, 2018
Folliculin mutation-negative trichodiscomas in a patient with multiple endocine neoplasia type I syndromeJennifer E Yeh, Steven R Tahan, Susan Burgin
JAMA Dermatology|January 10, 2024
Causes and Clinical Presentation of Drug-Induced Dermatomyositis: A Systematic ReviewSahar Caravan, Christopher M Lopez, Jennifer E Yeh
JAMA Oncology|October 28, 2021
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic ReviewEmily R Nadelmann, Jennifer E Yeh, Steven T Chen
Current Opinion in Oncology|September 20, 2013
Targeting transcription factors: promising new strategies for cancer therapyJennifer E Yeh, Patricia A Toniolo, David A Frank
JAAD Case Reports|March 1, 2021
Treatment of porokeratosis of Mibelli with combined use of topical fluorouracil and calcipotrieneJennifer E Yeh, Rosalynn M Nazarian, Mayra E Lorenzo
Dermatology Online Journal|March 13, 2024
Livedoid vasculopathyMelissa C Leeolou, Kerri E Rieger, Jennifer E Yeh
JAK-STAT|January 29, 2014
JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibitionJennifer E Yeh, Patricia A Toniolo, David A Frank
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
JAAD Case Reports|March 25, 2017
Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumabJennifer E Yeh, William G Tsiaras
Chemmedchem|December 15, 2015
STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer TherapyJennifer E Yeh, David A Frank
Dermatology Online Journal|August 1, 2024
Chronic ulcer in a patient with essential thrombocythemia taking hydroxyureaNolan Maloney, Roberto Novoa, Jennifer E Yeh
Dermatology Online Journal|February 23, 2018
Folliculin mutation-negative trichodiscomas in a patient with multiple endocine neoplasia type I syndromeJennifer E Yeh, Steven R Tahan, Susan Burgin
JAMA Dermatology|January 10, 2024
Causes and Clinical Presentation of Drug-Induced Dermatomyositis: A Systematic ReviewSahar Caravan, Christopher M Lopez, Jennifer E Yeh
JAMA Oncology|October 28, 2021
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic ReviewEmily R Nadelmann, Jennifer E Yeh, Steven T Chen
Current Opinion in Oncology|September 20, 2013
Targeting transcription factors: promising new strategies for cancer therapyJennifer E Yeh, Patricia A Toniolo, David A Frank
JAAD Case Reports|March 1, 2021
Treatment of porokeratosis of Mibelli with combined use of topical fluorouracil and calcipotrieneJennifer E Yeh, Rosalynn M Nazarian, Mayra E Lorenzo
Dermatology Online Journal|March 13, 2024
Livedoid vasculopathyMelissa C Leeolou, Kerri E Rieger, Jennifer E Yeh
JAK-STAT|January 29, 2014
JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibitionJennifer E Yeh, Patricia A Toniolo, David A Frank
Pageof 3